TGAN — Transphorm Technology Income Statement
0.000.00%
Last trade - 00:00- $300.95m
- $293.00m
- $16.51m
Annual income statement for Transphorm Technology, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 3 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-KT | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.9 | 11.4 | 2.42 | 24.1 | 16.5 |
| Cost of Revenue | |||||
| Gross Profit | 5.44 | 4.69 | 0.637 | 11.5 | -0.95 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 23.9 | 24.8 | 6.96 | 33.9 | 45.3 |
| Operating Profit | -11.9 | -13.4 | -4.54 | -9.9 | -28.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -15.3 | -17.9 | -6.58 | -10.2 | -30.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.3 | -17.9 | -6.58 | -10.2 | -30.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.3 | -17.9 | -6.58 | -10.2 | -30.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.3 | -17.9 | -6.58 | -10.2 | -30.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.435 | -0.551 | -0.163 | -0.218 | -0.494 |
| Dividends per Share |